Press releases

2024

2024-06-04 08:35 Warrants of series TO6 were exercised to approximately 44.8 percent and Prolight Diagnostics receives approximately SEK 9.8 million Regulatory MAR

2024-05-29 08:00 Prolight has obtained subscription commitments for exercising warrants of series TO6 from, among others, members of the Board and management of approximately SEK 1.0 million Regulatory

2024-05-28 08:00 Last day of trading with warrants of series TO6 in Prolight Diagnostics is today, May 28, 2024 Regulatory

2024-05-27 20:35 Annual general meeting of Prolight Diagnostics AB (publ) on 27 May 2024 Regulatory

2024-05-23 08:00 Prolight on track for clinical performance studies

2024-05-20 08:00 Prolight initiates trial at London hospital Trust supported by an NIHR i4i PDA grant

2024-05-20 07:45 The exercise period for warrants of series TO6 in Prolight Diagnostics begins today Regulatory

2024-05-17 08:15 Prolight Diagnostics publishes quarterly report Q1, 2024 Regulatory MAR

2024-05-17 08:00 Prolight Diagnostics awarded SEK17M UK government grant in collaboration with leading UK hospital Trust

2024-05-16 20:35 The exercise price for the warrants of series TO6 in Prolight Diagnostics has been determined to SEK 0.10 per share Regulatory